home / stock / pali / pali short
Short Information | Palisade Bio Inc. (NASDAQ:PALI)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 198,673 |
Total Actual Volume | 1,423,325 |
Short Trends | |
---|---|
Cover Days | 17 |
Short Days | 0 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 9,934 |
Average Short Percentage | 20.98% |
Is there a PALI Short Squeeze or Breakout about to happen?
See the PALI Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-22-2024 | $4.56 | $4.29 | $4.56 | $4.08 | 38,332 | 7,272 | 18.97% |
07-19-2024 | $4.877 | $4.33 | $4.89 | $3.8746 | 392,558 | 64,175 | 16.35% |
07-18-2024 | $4.27 | $4.35 | $4.4 | $4.22 | 12,727 | 4,129 | 32.44% |
07-17-2024 | $4.34 | $4.3 | $4.4335 | $4.18 | 13,021 | 1,503 | 11.54% |
07-16-2024 | $4.3 | $4.425 | $4.6599 | $4.22 | 105,037 | 38,614 | 36.76% |
07-15-2024 | $4.54 | $4.3 | $4.54 | $4.18 | 40,309 | 11,121 | 27.59% |
07-12-2024 | $4.33 | $4.54 | $4.54 | $4.25 | 32,531 | 3,910 | 12.02% |
07-11-2024 | $4.47 | $4.49 | $4.7 | $4.15 | 614,838 | 27,611 | 4.49% |
07-10-2024 | $4.35 | $4.47 | $4.5 | $4.33 | 7,587 | 1,577 | 20.79% |
07-09-2024 | $4.52 | $4.42 | $4.67 | $4.41 | 26,351 | 11,037 | 41.88% |
07-08-2024 | $4.44 | $4.47 | $4.637 | $4.3713 | 11,288 | 3,365 | 29.81% |
07-05-2024 | $4.5 | $4.49 | $4.5166 | $4.34 | 9,607 | 620 | 6.45% |
07-03-2024 | $4.7 | $4.35 | $4.7 | $4.35 | 11,335 | 1,727 | 15.24% |
07-02-2024 | $4.3 | $4.54 | $4.5699 | $4.3 | 8,182 | 3,486 | 42.61% |
07-01-2024 | $4.72 | $4.3 | $4.72 | $4.3 | 16,419 | 2,452 | 14.93% |
06-28-2024 | $4.57 | $4.5 | $4.57 | $4.4401 | 7,675 | 800 | 10.42% |
06-27-2024 | $4.5201 | $4.57 | $4.6 | $4.5 | 9,974 | 345 | 3.46% |
06-26-2024 | $4.69 | $4.58 | $4.763 | $4.52 | 12,638 | 4,223 | 33.42% |
06-25-2024 | $4.64 | $4.47 | $4.83 | $4.47 | 26,588 | 5,648 | 21.24% |
06-24-2024 | $4.71 | $4.62 | $4.76 | $4.51 | 26,328 | 5,058 | 19.21% |
News, Short Squeeze, Breakout and More Instantly...
Patent includes Composition of Matter claims for both PALI-2108 and PALI-1908 programs Patent includes broad claims for “Gut Microbiota Bioactivated PDE4 Inhibitor Precursors” with similar structure to PALI-2108 and PALI-1908 This patent family provides Composition o...
Company has now completed murine and non-murine pivotal nonclinical studies using GMP PALI-2108 drug substance Company has successfully formulated enteric-coated tablets of PALI-2108 and has demonstrated consistent and reliable drug release profiles Company on track to commence Ph...
Live video webcast on Wednesday, June 26 th at 4:00 PM ET Carlsbad, CA, June 24, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), biopharmaceutical company focused on developing and advancing novel...